CD133+ autologous bone marrow cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD133+ autologous bone marrow cells, covering 2020-04-02 to 2020-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery [Phase 4]